MedaSystems

Creating systems to enable communication between life sciences, doctors and patients.

[MedaSystems @MedaSystems]

Our flexible collaboration platform now offers support for Investigator-Initiated Studies, in addition to enabling Post-Trial Access and Expanded Access programs.

More information at: https://t.co/eVDNu0zr1M

#pharma #biotech #managedaccess

[MedaSystems @MedaSystems]

We are pleased to announce that MedaSystems has completed a SOC 2 Type 1 audit.

As the leader in providing SaaS Expanded Access software, this represents a significant milestone demonstrating our commitment to data security, patient privacy, and compliance.

[MedaSystems @MedaSystems]

Next week we'll be at #NORDSummit and Operationalise Early Access Programmes Europe. Reach out - we'd love to see you there!

#expandedaccess #managedaccess

[MedaSystems @MedaSystems]

We've introduced a new feature that automatically highlights any PHI that is found in incoming request and prompts the user to accept or overrule suggested redactions.

Read all about it! https://t.co/U3FfbU12JF

[MedaSystems @MedaSystems]

Transform your email and spreadsheet EAP process with flexible forms! Read all about it in the latest MedaSystems blog post: https://t.co/dENJJNcK7g

[MedaSystems @MedaSystems]

The 21st Century Cures Act requires that companies developing investigational therapies to publish their Expanded Access policy. A recent study estimates that 90% of companies are not yet fully compliant.

Find out what your policy must include. https://t.co/9z1FSR6X0l

[Fiona Smythe @fionasmythe]

A great mentor is a unique and wonderful asset - mine is the great ⁦@kenjross⁩ - reflecting here on
“50 years of software — some things never change” https://t.co/S1x4s0OcvD

[MedaSystems @MedaSystems]

We're delighted to be new members of @biocom.

https://t.co/WRWRl0Km7S

[Biocom @Biocom]

Newest members on #NewMemberMonday!
💬@MedaSystems offers software for collaboration btwn life sciences teams & physicians
🧠@aspenbio is developing the first autologous neuron replacement for Parkinson’s disease
🏭@PPlasticsIM produces injection molds and molded plastic parts

[Biocom @Biocom]

Newest members on #NewMemberMonday!
💬@MedaSystems offers software for collaboration btwn life sciences teams & physicians
🧠@aspenbio is developing the first autologous neuron replacement for Parkinson’s disease
🏭@PPlasticsIM produces injection molds and molded plastic parts

[MedaSystems @MedaSystems]

Respond to Expanded Access requests quickly with a clear structured process tailored for your process. Learn more about how MedaSystems can help you adhere to your SOPs at https://t.co/XM995LJ6YX

[MedaSystems @MedaSystems]

We are looking for you, our next Full-Stack Engineer!

Learn more at https://t.co/Z97tfBCP7O

[MedaSystems @MedaSystems]

Interested in running an Expanded Access program? MedaSystems can step you through the process (literally). Configurable checklists make it easy to collaborate with physicians to gather and review documentation.

Learn more at https://t.co/C96HmwCWsr
#compassionateuse #pharma

[MedaSystems @MedaSystems]

Our team will be at @ASCO this weekend. DM us to connect with them there and learn about how our Expanded Access platform can help your team!

#ASCO22

[nina.capital @ninacapital]

What an amazing time with our founders today, bonding and exchanging best practices & lessons learnt! We are very proud of our #ninafamily. Thanks for joining us! #wearenina

[MedaSystems @MedaSystems]

FDA is proposing adding an optional item to expanded access request forms, better understand whether racial and ethnic minorities are accessing medications through expanded access.

https://t.co/qy9axSgVFb

[MedaSystems @MedaSystems]

Thanks for the shoutout!

[MedaSystems @MedaSystems]

We're big fans of our furry canine friends, but it turns out they are even more amazing than we knew.
Meet America's Cancer Sniffing Canines!
https://t.co/DK2P5ZKzG6

[nina.capital @ninacapital]

NEWS! We are thrilled to announce our investment in @MedaSystems, an expanded access/managed access software for life science companies & physicians, on a mission to help patients gain access to investigational therapies. Read more:
https://t.co/IBbGPxpoG1 #wearenina

[MedaSystems @MedaSystems]

We are excited to announce the completion of a $1.5 million pre-seed funding round, led by specialist healthtech venture capital fund @ninacapital, in conjunction with a group of strategic angel investors.
#digitalhealth #pharmatech

[MedaSystems @MedaSystems]

An exciting Product Management opportunity in the #digitalhealth market - https://t.co/E1ESOiE7pt